Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Loracarbef (equivalent to 200 mg, 400 mg loracarbef anhydrate capsules Eli Lilly Italia S.p.A., Sesto, Fiorentino (Firenze), Italy and Eli Lilly Industries Inc., Carolina, Puerto Rico Lorabid Loracarbef (equivalent to 100 mg/5 ml, 200 mg/5 ml loracarbef anhydrate) granules for oral suspension Eli Lilly Italia S.p.A., Sesto, Fiorentino (Firenze), Italy and Eli Lilly Industries Inc., Carolina, Puerto Rico Lorabid Prednisolone 1 mg, 5 mg tablets Douglas Pharmaceuticals Ltd., Technical Division, Mount Roskill, Auckland Estradiol 2 mg (8g released per 24 hours) vaginal ring Dow Corning Health Care Centre, Valbonne Cedex, France Estring Carboplatin 10 mg/ml solution for injection ABIC Limited, Kiryat Nordau, Netanya, Israel Dated this 4th day of February 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.